Download PDF
1 / Pages

Other users also viewed these articles

Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-¿B signaling Yingwei Zhu; Hong Tang; Han Zhao; Jian Lu; Kai Lin; Jingbin Ni; Bo Zhao; Gaojue Wu; Chunxiao Tan;
Gastroenterol Hepatol. 2024;47:366-76
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study Ignacio Marín-Jiménez; Manuel Barreiro-de Acosta; María Esteve; Luisa Castro-Laria; Santiago García-López; Daniel Ceballos; Ana Echarri; María Dolores Martín-Arranz; David Busquets; Jordina Llaó; Mercè Navarro-Llavat; José María Huguet; Federico Argüelles-Arias; Raquel Vicente; José Miguel Boudet; Gema Díaz; Ana M. Sánchez-Migallón; Francesc Casellas;
Gastroenterol Hepatol. 2022;45:165-76
Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease¿EXVEDOCOL Viviana Parra; Sandra Cifuentes; Sandra Avendaño; Enrique Ponce de León; Cristian Florez; Gustavo Reyes; Fabian Puentes; Manuel Ballesteros; Edilberto Nuñez; Federico Gómez; Juan Ricardo Márquez;
Gastroenterol Hepatol. 2024;47:858-66